HEGSETH ORDERS ANNUAL TESTOSTERONE SCREENING FOR US TROOPSCOMPARATIVE VIEW
EXPLORE THIS STORY
SHARE THIS COMPARISON
Show your friends how the world sees the same news differently.
Defense Secretary Pete Hegseth orders annual testosterone screening for US military members over 30, under the banner of a 'High-T Department of War'. The move triggers mockery, analysis and debate over masculinity and military readiness worldwide.
🇧🇪 Belgium vs 🇵🇰 Pakistan
FRAMING GAP
86/100HIGH
Perspectives diverge strongly
Here are the main framing differences identified between media coverages.
ANALYSIS BY COUNTRY
BELGIUMDOMINANT ANGLE
Brussels is questioning the boundary between biological optimization and the medicalization of the US military, amid concerns about gray areas regarding female soldiers.
Dominant angle identified — does not reflect unanimity of this country’s media
KEY POINTS
- •Starting at 30, Belgian soldiers will undergo an annual testosterone test as part of their medical checkup; treatment will be recommended but not mandatory in case of deficiency, and those under 30 can do so voluntarily.
- •Belgium's government justifies the measure as a "sacred duty" aimed at preserving the "individual fighter", the country's main tactical advantage, under the name "The High-T Department of War".
- •Belgium's capital notes that the application to female military personnel remains uncertain, and recalls that the government has already linked access to combat roles to a "higher male standard", echoing the exclusion of transgender military personnel.
BIASES
Belgium's capital, Brussels, sees the issue through a US-centric lens, with Belgian media largely relaying Pentagon talking points without input from independent Belgian or European medical experts.Belgian government officials tend to favor factual reporting, with limited context on how the country's military doctrine aligns with European standards on sports medicine and soldier longevity.The Belgian perspective also falls short in covering the female aspect, as the issue of including female military personnel in screening efforts is raised but not explored in depth through official or associative responses.
PAKISTANDOMINANT ANGLE
Pakistan's capital views the Pentagon's announcement as a new chapter in the politicization of US military health, caught between disputed science and partisan battles.
Dominant angle identified — does not reflect unanimity of this country’s media
KEY POINTS
- •Pakistan's government is considering a proposal by Hegseth to implement annual testosterone screening for military personnel aged 30 and above, with optional hormone therapy for those diagnosed with a deficiency
- •Pakistan's capital, Islamabad, is where Dr Mohit Khera, a former FDA expert panel head, tells the BBC that all men over 30 should be tested
- •Pakistani Americans, including Democratic lawmakers Summer Lee and Tammy Duckworth, accuse Hegseth of inconsistency, citing his ban on transgender military personnel who rely on hormone therapy
BIASES
Pakistan's government views the controversy as being largely framed as a US domestic policy issue, lacking regional contextPakistani outlets reprint nearly identical versions of the same report, without adding local perspective or Pakistani reactionLimited coverage of the independent scientific aspect of the issue, with the sole medical voice cited coming from a US official panel
BELGIUMDOMINANT ANGLE
Brussels is questioning the boundary between biological optimization and the medicalization of the US military, amid concerns about gray areas regarding female soldiers.
Dominant angle identified — does not reflect unanimity of this country’s media
KEY POINTS
- •Starting at 30, Belgian soldiers will undergo an annual testosterone test as part of their medical checkup; treatment will be recommended but not mandatory in case of deficiency, and those under 30 can do so voluntarily.
- •Belgium's government justifies the measure as a "sacred duty" aimed at preserving the "individual fighter", the country's main tactical advantage, under the name "The High-T Department of War".
- •Belgium's capital notes that the application to female military personnel remains uncertain, and recalls that the government has already linked access to combat roles to a "higher male standard", echoing the exclusion of transgender military personnel.
BIASES
Belgium's capital, Brussels, sees the issue through a US-centric lens, with Belgian media largely relaying Pentagon talking points without input from independent Belgian or European medical experts.Belgian government officials tend to favor factual reporting, with limited context on how the country's military doctrine aligns with European standards on sports medicine and soldier longevity.The Belgian perspective also falls short in covering the female aspect, as the issue of including female military personnel in screening efforts is raised but not explored in depth through official or associative responses.
PAKISTANDOMINANT ANGLE
Pakistan's capital views the Pentagon's announcement as a new chapter in the politicization of US military health, caught between disputed science and partisan battles.
Dominant angle identified — does not reflect unanimity of this country’s media
KEY POINTS
- •Pakistan's government is considering a proposal by Hegseth to implement annual testosterone screening for military personnel aged 30 and above, with optional hormone therapy for those diagnosed with a deficiency
- •Pakistan's capital, Islamabad, is where Dr Mohit Khera, a former FDA expert panel head, tells the BBC that all men over 30 should be tested
- •Pakistani Americans, including Democratic lawmakers Summer Lee and Tammy Duckworth, accuse Hegseth of inconsistency, citing his ban on transgender military personnel who rely on hormone therapy
BIASES
Pakistan's government views the controversy as being largely framed as a US domestic policy issue, lacking regional contextPakistani outlets reprint nearly identical versions of the same report, without adding local perspective or Pakistani reactionLimited coverage of the independent scientific aspect of the issue, with the sole medical voice cited coming from a US official panel